Antiplatelet and anticoagulant agents in vitreoretinal surgery: a prospective multicenter study involving 804 patients.

Cyril MeillonPierre Henry GabrielleMaxime LuuLudwig S Aho-GleleAlain-Marie BronCatherine Creuzot-Garchernull null

Published in: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie (2018)

This study showed that AP and AC agents were not a factor associated with hemorrhagic complications during vitreoretinal surgery. The continuation of these treatments should be considered without risk of severe hemorrhagic complications.

Keyphrases

minimally invasive
coronary artery bypass
end stage renal disease
ejection fraction
chronic kidney disease
risk factors
venous thromboembolism
peritoneal dialysis
atrial fibrillation
prognostic factors
early onset
coronary artery disease